Ionis Pharmaceuticals, Inc.
Methods for monitoring C9ORF72 expression
Last updated:
Abstract:
Disclosed herein are methods for monitoring expression of C9ORF72 mRNA and protein in an animal with C9ORF72 specific inhibitors. Such C9ORF72 specific inhibitors include antisense compounds.
Status:
Grant
Type:
Utility
Filling date:
15 Oct 2013
Issue date:
3 Mar 2020